Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment or prepayment of borrowings
Funds from the fresh issue are earmarked to repay or prepay certain outstanding borrowings from banks and financial institutions.
General corporate purposes
-
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
GPT Healthcare Limited, incorporated in 1989 and headquartered in Kolkata, is a regional multi-specialty hospital operator in Eastern India that runs its facilities under the ILS Hospitals brand. The company focuses on secondary and tertiary care, delivering services across more than 35 medical specialties and super-specialties including internal medicine, nephrology, surgery, and gynecology, alongside diagnostic and pharmacy operations. As of mid-2023 the company operated four hospitals located in Salt Lake, Dum Dum and Howrah in West Bengal and in Agartala, Tripura, together housing 561 beds. The workforce comprised roughly 1,855 employees supported by 85 full time consultants and 465 visiting consultants, reflecting a fairly asset light medical staffing model layered onto owned hospital infrastructure. The company is promoted by the Tantia family through GPT Sons Private Limited alongside individual promoters Dwarika Prasad Tantia, Dr. Om Tantia and Shree Gopal Tantia, and carries the corporate identification number L70101WB1989PLC047402. Revenue grew from about Rs 248.86 crore in FY2021 to Rs 342.40 crore in FY2022 and Rs 366.73 crore in FY2023, aided by the broader recovery in regional healthcare demand, while profitability has moved with a somewhat uneven cadence typical of a hospital operator scaling new capacity. Positioned as one of the larger regional corporate hospital chains in Eastern India by bed count and hospital count, the company's growth strategy centers on deepening its presence in West Bengal and neighbouring states and broadening its specialty mix. Its shares listed on the NSE and BSE on 29 February 2024 following a book built public issue.
The anchor book raised about Rs 157.54 crore at the top end of the price band, allocated to institutions including Societe Generale, Kotak Mutual Fund, Axis Mutual Fund, Bandhan, Copthall Mauritius, Aditya Birla Life Insurance, LC Pharos Multi Strategy Fund, and DE Shaw Valence International.
Source: RHP • Analysis provided for informational purposes
Last Updated: 17 July 2026, 5:30 AM
Established regional hospital network
The company runs four multi-specialty hospitals with 561 beds across West Bengal and Tripura, making it one of the larger corporate hospital chains in Eastern India by hospital and bed count.
Broad specialty coverage
Services span more than 35 medical specialties and super-specialties, supported by a mix of full time and visiting consultants, letting the group serve a wide range of secondary and tertiary care needs from a compact hospital base.
Consistent revenue growth
Revenue rose from about Rs 249 crore in FY2021 to about Rs 367 crore in FY2023, pointing to steady demand growth across its hospital network.
Geographic concentration
Roughly 70 percent of revenue comes from hospitals located in West Bengal, leaving the business exposed to regional demand, competition, or regulatory shifts in a single state.
Promoter compliance issue
A promoter group member has featured on a wilful defaulters list and had a demat account frozen by the depository for non-compliance at an associated entity, a governance flag investors should weigh.
MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.